Business Segments Sun Pharmaceutical Industries Ltd.
Equities
SUNPHARMA
INE044A01036
Pharmaceuticals
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,609.40 INR | -3.94% |
|
-7.13% | -6.25% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Pharmaceuticals | 335B | 387B | 439B | 485B | 526B | |||||
Total Assets | 677B | 698B | 807B | 855B | 921B | |||||
Interest Expense | -1.41B | -1.27B | -1.72B | -2.38B | -2.31B | |||||
Income Tax Expense | 5.15B | 10.76B | 8.48B | 14.39B | 27.72B | |||||
CAPEX | -11.7B | -14.95B | -20.86B | -22.02B | -21.29B | |||||
EBT | 27.99B | 44.81B | 94.08B | 111B | 138B | |||||
D&A | 20.3B | 21.09B | 24.77B | 24.91B | 25.07B | |||||
Net Income | 29.04B | 32.73B | 84.74B | 95.76B | 109B |
Geographical Revenue Distribution History
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
India | 109B | 134B | 142B | 154B | 174B | |||||
Total Assets | - | 130B | 124B | 113B | 107B | |||||
United States of America | 104B | 117B | 140B | 159B | 170B | |||||
Total Assets | - | 13.45B | 55.63B | 56.6B | 55.19B | |||||
Emerging Markets | 64.05B | 72.76B | 85.63B | 92.42B | 99.56B | |||||
Total Assets | - | 10.62B | 13.58B | 13.24B | 24.26B | |||||
Rest of The World | 54.28B | 59.73B | 65.83B | 72.35B | 77.02B | |||||
Total Assets | - | 20.89B | 17.79B | 21.71B | 21.74B | |||||
Outside India | - | - | - | - | - |
Select your edition
All financial news and data tailored to specific country editions
